Compare AREN & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AREN | DRIO |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6M | 60.6M |
| IPO Year | 2017 | 2013 |
| Metric | AREN | DRIO |
|---|---|---|
| Price | $1.05 | $6.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 116.0K | 5.6K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 191.93 | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $16,892,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | $5.00 | $47.58 |
| P/E Ratio | ★ N/A | $5.54 |
| Revenue Growth | 27.46 | ★ 43.02 |
| 52 Week Low | $1.05 | $0.38 |
| 52 Week High | $7.85 | $17.74 |
| Indicator | AREN | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 26.76 | 35.04 |
| Support Level | N/A | $6.16 |
| Resistance Level | $1.61 | $9.46 |
| Average True Range (ATR) | 0.12 | 0.37 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 0.00 | 3.00 |
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The company has four reportable segments: Sports & Leisure, Finance, Lifestyle, and Platform & Other. The company generates revenue from Sports & Leisure. Geographically, the company operates in United States; and Others. It generates maximum revenue from United States.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.